Pegloticase
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Pegloticase, covering 2021-10-11 to 2026-07-01. Get the full timeline:
Most recent: Clinical Trial Results: A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout [Phase 4]